The Role of TLR4 on B Cell Activation and Anti-β(2)GPI Antibody Production in the Antiphospholipid Syndrome.

The Role of TLR4 on B Cell Activation and Anti-β(2)GPI Antibody Production in the Antiphospholipid Syndrome.
复制标题

TLR4 在抗磷脂综合征中 B 细胞激活和抗 β(2)GPI 抗体产生中的作用

DOI:
10.1155/2016/1719720
复制
发表时间:
2016
影响因子:
4.1
通讯作者:
Zhou H
Zhou H
中科院分区:
医学3区
文献类型:
--
作者:
Cheng S;Wang H;Zhou H

文献摘要

参考文献

被引文献

相似文献

高滴度抗β2-糖蛋白I抗体(抗β2GPI Ab)在抗磷脂综合征(APS)中起致病作用。许多研究都集中在AP的发病机制上,而抗β2GPI抗体在AP中产生的免疫机制却鲜有人关注。我们先前的研究表明,Toll样受体4(TLR4)在人β2-糖蛋白I(β2GPI)免疫的小鼠骨髓来源的树突状细胞(BMDCs)成熟过程中起着至关重要的作用。在β2GPI处理的小鼠中,TLR4是激活B细胞和产生自身抗体所必需的。而TLR4为B细胞的激活提供第三种信号,进而促进B细胞更好地接受B细胞抗原受体和CD40的信号,从而促进B细胞活化、表面分子表达、抗β2GPI抗体的产生和细胞因子的分泌,使B细胞发挥抗原提呈细胞的功能。同时,TLR4还通过上调B细胞激活因子(BAFF)的表达促进B细胞产生抗体。本文就TLR4在自身免疫性疾病APS的B细胞免疫应答和抗体产生中的作用作一综述,以期为APS的防治寻找新的途径。
High titer of anti-β 2-glycoprotein I antibodies (anti-β 2GPI Ab) plays a pathogenic role in antiphospholipid syndrome (APS). Numerous studies have focused on the pathological mechanism in APS; however, little attention is paid to the immune mechanism of production of anti-β 2GPI antibodies in APS. Our previous study demonstrated that Toll-like receptor 4 (TLR4) plays a vital role in the maturation of bone marrow-derived dendritic cells (BMDCs) from the mice immunized with human β 2-glycoprotein I (β 2GPI). TLR4 is required for the activation of B cells and the production of autoantibody in mice treated with β 2GPI. However, TLR4 provides a third signal for B cell activation and then promotes B cells better receiving signals from both B cell antigen receptor (BCR) and CD40, thus promoting B cell activation, surface molecules expression, anti-β 2GPI Ab production, and cytokines secretion and making B cell functioning like an antigen presenting cell (APC). At the same time, TLR4 also promotes B cells producing antibodies by upregulating the expression of B-cell activating factor (BAFF). In this paper, we aim to review the functions of TLR4 in B cell immune response and antibody production in autoimmune disease APS and try to find a new way for the prevention and treatment of APS.
DOI: 10.1371/journal.pone.0025542
发表时间: 2011
期刊: PloS one
影响因子: 3.7
作者:
Boeglin E;Smulski CR;Brun S;Milosevic S;Schneider P;Fournel S
通讯作者: Fournel S
DOI: 10.1186/1471-2172-15-22
发表时间: 2014-06-07
期刊: BMC immunology
影响因子: 3
作者:
Bornacelly A;Mercado D;Acevedo N;Caraballo L
通讯作者: Caraballo L
DOI: 10.1182/blood-2011-09-378851
发表时间: 2012-10-18
期刊: BLOOD
影响因子: 20.3
作者:
Colasanti, Tania;Alessandri, Cristiano;Margutti, Paola
通讯作者: Margutti, Paola
DOI: 10.4049/jimmunol.0901689
发表时间: 2010-07-01
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者:
Bolduc A;Long E;Stapler D;Cascalho M;Tsubata T;Koni PA;Shimoda M
通讯作者: Shimoda M
DOI: 10.1016/j.jdiacomp.2013.05.002
发表时间: 2013-09
影响因子: 3
作者:
Dasu MR;Jialal I
通讯作者: Jialal I